Question 1

Has Jeffrey Klassen, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $80,386 in general payments to Jeffrey Klassen, MD across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Jeffrey Klassen, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Jeffrey Klassen, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Arthrex	27	$69,456
Steris Corporation	2	$4,770
Foundation Medical, LLC	14	$2,233
Johnson & Johnson	14	$1,476
Gemini Medical LLC	10	$1,446
Stryker(2 entities)	6	$373
Anika Therapeutics, Inc.	3	$214
Zimmer Biomet	3	$176
Smith+Nephew	2	$116
Medical Device Business Services, Inc.	2	$70
Catalyst Orthoscience	1	$40
Novo Nordisk	1	$16

Jeffrey Klassen, MD

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Medicare billing

Other orthopaedic surgery in Crosby